From pre-clinical in vitro and in vivo modelling, clinical trials, public health research, developing Artificial Intelligence and machine learning to understand neurodegeneration, we are tackling dementia at a cross-faculty strategic level. We have invested in a dedicated human PET-MRI facility, have secured NIHR infrastructure and major UKRI programmes to be at the forefront of dementia research.
Already the first site in the UK to trial genetic therapy for Alzheimer鈥檚 disease and motor neuron disease, 91直播 is becoming one of the major centres in the UK for advanced therapies for neurological diseases as one of three MRC/LifeArc Gene Therapy Innovation Hubs. The 91直播 Institute for Translational Neuroscience (SITraN) has been central in establishing the translational neuroscience research community in 91直播, building the underpinning science for the 鈥減ull-through鈥 of therapeutic developments, and the evidence base for clinical interventions.
This is an outstanding opportunity to join the Department of Neuroscience and make a contribution to the major themes of neurological research at the University and to lead and enhance our translational research in the area of dementia. These new posts have arisen from a strategic initiative within the University to build on our successful translational neurodegeneration portfolio.
We are recruiting for two vacancies:
Senior Clinical Academic in Dementia / Neurodegeneration
Job description: Senior Academic in Dementia / Neurodegneration
Info pack: Senior Academic in Dementia / Neurodegneration
Scientific Researcher in Dementia / Neurodegeneration
Job description: Scientific Researcher in Dementia / Neurodegeneration
Info pack: Scientific Researcher in Dementia / Neurodegeneration